Creatine, a naturally occurring compound, enhances athletic performance and shows potential health benefits, but caution and ...

Merck’s phase 3 HYPERION study of Winrevair meets primary endpoint in recently diagnosed adults with pulmonary arterial hypertension: Rahway, New Jersey Tuesday, June 24, 2025, ...

Skin grafts genetically engineered from a patient's own cells can heal persistent wounds in people with an extremely painful ...

Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...

Most gene therapies being studied for eye diseases are in earlier phases of development, and a third of the gene therapies ...

Discover what clinical trials are, why they're vital for new treatments, and how you can participate in life-changing medical ...

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...

The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Europe conference, which took place between 29 and 30 April in Barcelona, Spain, industry experts delivered comprehensive ...

Optical coherence tomography markers—like the ellipsoid zone—are reshaping clinical trials in intermediate age-related ...